Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660

Article  CAS  PubMed  Google Scholar 

Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, Bray F (2020) Global burden of 5 major types of gastrointestinal cancer. Gastroenterology 159(335–349):e315. https://doi.org/10.1053/j.gastro.2020.02.068

Article  Google Scholar 

Ding J, Wen Z (2021) Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database. BMC Cancer 21:1157. https://doi.org/10.1186/s12885-021-08904-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Landras A, Reger de Moura C, Jouenne F, Lebbe C, Menashi S, Mourah S (2019) CD147 Is a promising target of tumor progression and a prognostic biomarker. Cancers (Basel) 11:1803. https://doi.org/10.3390/cancers11111803

Article  CAS  PubMed  Google Scholar 

Huang D, Rao D, Jin Q, Lai M, Zhang J, Lai Z, Shen H, Zhong T (2023) Role of CD147 in the development and diagnosis of hepatocellular carcinoma. Front Immunol 14:1149931. https://doi.org/10.3389/fimmu.2023.1149931

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nyalali AMK, Leonard AU, Xu Y, Li H, Zhou J, Zhang X, Rugambwa TK, Shi X, Li F (2023) CD147: an integral and potential molecule to abrogate hallmarks of cancer. Front Oncol 13:1238051. https://doi.org/10.3389/fonc.2023.1238051

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peng F, Li H, You Q, Li H, Wu D, Jiang C, Deng G, Li Y, Li Y, Wu Y (2017) CD147 as a novel prognostic biomarker for hepatocellular carcinoma: a meta-analysis. Biomed Res Int 2017:5019367. https://doi.org/10.1155/2017/5019367

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Q, Zhou J, Ku XM, Chen XG, Zhang L, Xu J, Chen GS, Li Q, Qian F, Tian R, Wen N, Chen ZN (2007) Expression of CD147 as a significantly unfavorable prognostic factor in hepatocellular carcinoma. Eur J Cancer Prev 16:196–202. https://doi.org/10.1097/01.cej.0000236245.40619.c3

Article  PubMed  Google Scholar 

Zhu S, Li Y, Zhang Y, Wang X, Gong L, Han X, Yao L, Lan M, Zhang W (2015) Expression and clinical implications of HAb18G/CD147 in hepatocellular carcinoma. Hepatol Res 45:97–106. https://doi.org/10.1111/hepr.12320

Article  CAS  PubMed  Google Scholar 

Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, Nabeshima K (1995) The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 55:434–439

CAS  PubMed  Google Scholar 

Xu J, Xu HY, Zhang Q, Song F, Jiang JL, Yang XM, Mi L, Wen N, Tian R, Wang L, Yao H, Feng Q, Zhang Y, Xing JL, Zhu P, Chen ZN (2007) HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma. Mol Cancer Res 5:605–614. https://doi.org/10.1158/1541-7786.MCR-06-0286

Article  CAS  PubMed  Google Scholar 

Ru NY, Wu J, Chen ZN, Bian H (2015) HAb18G/CD147 is involved in TGF-beta-induced epithelial-mesenchymal transition and hepatocellular carcinoma invasion. Cell Biol Int 39:44–51. https://doi.org/10.1002/cbin.10341

Article  CAS  PubMed  Google Scholar 

Levy MT, Trojanowska M, Reuben A (2000) Oncostatin M: a cytokine upregulated in human cirrhosis, increases collagen production by human hepatic stellate cells. J Hepatol 32:218–226. https://doi.org/10.1016/s0168-8278(00)80066-5

Article  CAS  PubMed  Google Scholar 

Znoyko I, Sohara N, Spicer SS, Trojanowska M, Reuben A (2005) Expression of oncostatin M and its receptors in normal and cirrhotic human liver. J Hepatol 43:893–900. https://doi.org/10.1016/j.jhep.2005.04.020

Article  CAS  PubMed  Google Scholar 

Di Maira G, Foglia B, Napione L, Turato C, Maggiora M, Sutti S, Novo E, Alvaro M, Autelli R, Colombatto S, Bussolino F, Carucci P, Gaia S, Rosso C, Biasiolo A, Pontisso P, Bugianesi E, Albano E, Marra F, Parola M, Cannito S (2022) Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis. J Pathol 257:82–95. https://doi.org/10.1002/path.5871

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shigematsu Y, Tanaka K, Amori G, Kanda H, Takahashi Y, Takazawa Y, Takeuchi K, Inamura K (2023) Potential involvement of oncostatin M in the immunosuppressive tumor-immune microenvironment in hepatocellular carcinoma with vessels encapsulating tumor clusters. Hepatol Res. https://doi.org/10.1111/hepr.13988

Article  PubMed  Google Scholar 

Chan AW, Kumada T, Toyoda H, Tada T, Chong CC, Mo FK, Yeo W, Johnson PJ, Lai PB, Chan AT, To KF, Chan SL (2016) Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma. J Gastroenterol Hepatol 31:1300–1306. https://doi.org/10.1111/jgh.13291

Article  CAS  PubMed  Google Scholar 

Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP (2017) The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin 67:93–99. https://doi.org/10.3322/caac.21388

Article  PubMed  Google Scholar 

Torbenson M, Ng IOL, Park YN, Roncalli M, Sakamoto M (2019) Hepatocellular carcinoma. In: WHO classification of tumours editorial board, editor. Digestive system tumours. International Agency for Research on Cancer, Lyon

Kudo M, Kawamura Y, Hasegawa K, Tateishi R, Kariyama K, Shiina S, Toyoda H, Imai Y, Hiraoka A, Ikeda M, Izumi N, Moriguchi M, Ogasawara S, Minami Y, Ueshima K, Murakami T, Miyayama S, Nakashima O, Yano H, Sakamoto M, Hatano E, Shimada M, Kokudo N, Mochida S, Takehara T (2021) Management of hepatocellular carcinoma in Japan: JSH consensus statements and recommendations 2021 update. Liver Cancer 10:181-223. https://doi.org/10.1159/000514174

Brunt EM, Tiniakos DG (2010) Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol 16:5286–5296. https://doi.org/10.3748/wjg.v16.i42.5286

Article  PubMed  PubMed Central  Google Scholar 

Shigematsu Y, Amori G, Kanda H, Takahashi Y, Takazawa Y, Takeuchi K, Inamura K (2022) Decreased ARG1 expression as an adverse prognostic phenotype in non-alcoholic non-virus-related hepatocellular carcinoma. Virchows Arch 481:253–263. https://doi.org/10.1007/s00428-022-03318-3

Article  CAS  PubMed  Google Scholar 

Shigematsu Y, Inamura K, Yamamoto N, Mise Y, Saiura A, Ishikawa Y, Takahashi S, Kanda H (2018) Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis. BMC Cancer 18:980. https://doi.org/10.1186/s12885-018-4902-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676–682. https://doi.org/10.1038/nmeth.2019

Article  CAS  PubMed  Google Scholar 

Caligiuri A, Gitto S, Lori G, Marra F, Parola M, Cannito S, Gentilini A (2022) Oncostatin M: from intracellular signaling to therapeutic targets in liver cancer. Cancers (Basel) 14:4211. https://doi.org/10.3390/cancers14174211

Article  CAS  PubMed  Google Scholar 

Xu YJ, He HJ, Wu P, Li WB (2023) Expression patterns of cluster of differentiation 147 impact the prognosis of hepatocellular carcinoma. World J Gastrointest Oncol 15:1412–1423. https://doi.org/10.4251/wjgo.v15.i8.1412

Article  PubMed  PubMed Central  Google Scholar 

Guo F, Li H, Wang L, Song X, Wang J, Feng Q, Zong J (2022) Rs6757 in microRNA-3976 binding site of CD147 confers risk of hepatocellular carcinoma in South Chinese population. World J Surg Oncol 20:260. https://doi.org/10.1186/s12957-022-02724-w

Article  PubMed  PubMed Central  Google Scholar 

Zhang JJ, Song CG, Dai JM, Zhang XQ, Lin P, Li L, Yang XM, Chen ZN (2021) Inhibition of mu-opioid receptor suppresses proliferation of hepatocellular carcinoma cells via CD147-p53-MAPK cascade signaling pathway. Am J Transl Res 13:3967–3986

CAS  PubMed  PubMed Central  Google Scholar